BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34437329)

  • 21. Thrombosis and Bleeding in Extracorporeal Membrane Oxygenation (ECMO) Without Anticoagulation: A Systematic Review.
    Olson SR; Murphree CR; Zonies D; Meyer AD; Mccarty OJT; Deloughery TG; Shatzel JJ
    ASAIO J; 2021 Mar; 67(3):290-296. PubMed ID: 33627603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact and Statistical Analysis of a Multifaceted Anticoagulation Strategy in Children Supported on ECMO: Performance and Pitfalls.
    Kessel AD; Kline M; Zinger M; McLaughlin D; Silver P; Sweberg TM
    J Intensive Care Med; 2017 Jan; 32(1):59-67. PubMed ID: 26319579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation practices associated with bleeding and thrombosis in pediatric extracorporeal membrane oxygenation; a multi-center secondary analysis.
    Bailly DK; Reeder RW; Muszynski JA; Meert KL; Ankola AA; Alexander PM; Pollack MM; Moler FW; Berg RA; Carcillo J; Newth C; Berger J; Bell MJ; Dean JM; Nicholson C; Garcia-Filion P; Wessel D; Heidemann S; Doctor A; Harrison R; Dalton H; Zuppa AF
    Perfusion; 2023 Mar; 38(2):363-372. PubMed ID: 35220828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study.
    Mansour A; Flecher E; Schmidt M; Rozec B; Gouin-Thibault I; Esvan M; Fougerou C; Levy B; Porto A; Ross JT; Para M; Manganiello S; Lebreton G; Vincentelli A; Nesseler N;
    Intensive Care Med; 2022 Aug; 48(8):1039-1052. PubMed ID: 35829723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case report: Veno-venous extracorporeal membrane oxygenation for severe blunt thoracic trauma.
    Ogawa F; Sakai T; Takahashi K; Kato M; Yamaguchi K; Okazaki S; Abe T; Iwashita M; Takeuchi I
    J Cardiothorac Surg; 2019 May; 14(1):88. PubMed ID: 31060587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nafamostat mesilate as a regional anticoagulant in patients with bleeding complications during extracorporeal membrane oxygenation.
    Park JH; Her C; Min HK; Kim DK; Park SH; Jang HJ
    Int J Artif Organs; 2015 Nov; 38(11):595-9. PubMed ID: 26728787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemorrhage under veno-venous extracorporeal membrane oxygenation in acute respiratory distress syndrome patients: a retrospective data analysis.
    Kreyer S; Muders T; Theuerkauf N; Spitzhüttl J; Schellhaas T; Schewe JC; Guenther U; Wrigge H; Putensen C
    J Thorac Dis; 2017 Dec; 9(12):5017-5029. PubMed ID: 29312706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation.
    Stansfield BK; Wise L; Ham PB; Patel P; Parman M; Jin C; Mathur S; Harshfield G; Bhatia J
    J Pediatr Surg; 2017 Apr; 52(4):609-613. PubMed ID: 27847121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conventional versus restricted anti-Xa-guided heparin protocol in adult patients undergoing extracorporeal membrane oxygenation.
    Alkazemi A; Eche IM; Adra M; Cabezas F; Patel P; Rick K; Grandin EW
    Artif Organs; 2022 Jan; 46(1):128-137. PubMed ID: 34725832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis.
    Nunez JI; Gosling AF; O'Gara B; Kennedy KF; Rycus P; Abrams D; Brodie D; Shaefi S; Garan AR; Grandin EW
    Intensive Care Med; 2022 Feb; 48(2):213-224. PubMed ID: 34921625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation and Transfusions Management in Veno-Venous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: Assessment of Factors Associated With Transfusion Requirements and Mortality.
    Martucci G; Panarello G; Occhipinti G; Ferrazza V; Tuzzolino F; Bellavia D; Sanfilippo F; Santonocito C; Bertani A; Vitulo P; Pilato M; Arcadipane A
    J Intensive Care Med; 2019 Aug; 34(8):630-639. PubMed ID: 28460592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Satisfactory outcome with low activated clotting time in extracorporeal membrane oxygenation.
    Hong JI; Hwang J; Shin HJ
    Rev Cardiovasc Med; 2021 Dec; 22(4):1589-1594. PubMed ID: 34957799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of heparin assay for coagulation management in newborns undergoing ECMO.
    Khaja WA; Bilen O; Lukner RB; Edwards R; Teruya J
    Am J Clin Pathol; 2010 Dec; 134(6):950-4. PubMed ID: 21088159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulation and anticoagulation in extracorporeal membrane oxygenation.
    Muntean W
    Artif Organs; 1999 Nov; 23(11):979-83. PubMed ID: 10564301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemostatic alterations during extracorporeal membrane oxygenation in ovine veno-venous and veno-arterial models.
    Gao S; Zhang Y; Peng R; Yan S; Teng Y; Qi J; Cheng G; Yu D; Liu G; Xu Q; Cai X; Zhou Z; Ji B
    Artif Organs; 2023 Mar; 47(3):526-536. PubMed ID: 36310416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracorporeal membrane oxygenation-hemostatic complications.
    Murphy DA; Hockings LE; Andrews RK; Aubron C; Gardiner EE; Pellegrino VA; Davis AK
    Transfus Med Rev; 2015 Apr; 29(2):90-101. PubMed ID: 25595476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of anticoagulation considerations in extracorporeal membrane oxygenation support.
    Graboyes SDT; Owen PS; Evans RA; Berei TJ; Hryniewicz KM; Hollis IB
    Pharmacotherapy; 2023 Dec; 43(12):1339-1363. PubMed ID: 37519116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
    Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
    Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comparison of Activated Partial Thromboplastin Time and Activated Coagulation Time for Anticoagulation Monitoring during Extracorporeal Membrane Oxygenation Therapy.
    Liu Y; Yuan Z; Han X; Song K; Xing J
    Hamostaseologie; 2023 Jun; 43(3):171-178. PubMed ID: 35882351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Bivalirudin Dosing and Replacement Fluid During Therapeutic Plasma Exchange in Children on Extracorporeal Membrane Oxygenation.
    Chomat MR; Swanson K; Barton K; Douds M; Said AS
    ASAIO J; 2024 Mar; 70(3):e31-e37. PubMed ID: 38029748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.